<DOC>
	<DOCNO>NCT02755532</DOCNO>
	<brief_summary>Introduction : The risk systemic toxicity use bupivacaine persistent problem , make pharmacokinetic study crucial safety regional anesthesia ( RA ) . Little evidence exist regard effect different concentration drug peak plasma level . The present study compare two bupivacaine concentration establish concentration exchange area affect peak plasma level drug axillary brachial plexus block . Latency postoperative analgesia period also compare . Methods : 32 patient randomly assign two group . In 0.25 % group , 10 ml 0.25 % bupivacaine inject per nerve ; 0.5 % group , 5 ml 0.5 % bupivacaine inject per nerve . Peripheral blood sample collect every 15 min first hour every 30 min second hour establish serum level dosage . High-performance liquid chromatography couple mass spectrometry use analysis .</brief_summary>
	<brief_title>Bupivacaine Pharmacokinetics Ultrasound-guided Axillary Brachial Plexus Block .</brief_title>
	<detailed_description />
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>candidate elective surgery distal forearm hand brachial plexus anesthesia analgesia indicate . physical status I II accord American Society Anesthesiologists ( ASA ) criterion body mass index ( BMI ) less 35 kg/m2 Signed free informed consent document . cognitive impairment infection block puncture site coagulopathy history bupivacaine allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Bupivacaine</keyword>
	<keyword>Axillary brachial plexus block</keyword>
</DOC>